The study will enroll subjects who are indicated to receive an implantable single or dual chamber ICD, or CRT-D and who meet all of the inclusion criteria and none of the exclusion criteria. Subjects will receive an investigational Next Generation ICD Lead. Subjects will be followed for at least 18 months following Next Generation ICD Lead implantation.
The study is designed to assess the safety and efficacy of the Next Generation ICD lead.